Prevention of passively transferred experimental autoimmune myasthenia gravis by Fab fragments of monoclonal antibodies directed against the main immunogenic region of the acetylcholine receptor
- 1 May 2000
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 104 (2) , 124-132
- https://doi.org/10.1016/s0165-5728(99)00259-3
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Nicotinic acetylcholine receptor at 4.6 Å resolution: transverse tunnels in the channelJournal of Molecular Biology, 1999
- Characterisation, crystallisation and preliminary X‐ray diffraction analysis of a Fab fragment of a rat monoclonal antibody with very high affinity for the human muscle acetylcholine receptorFEBS Letters, 1996
- Passive transfer of experimental myasthenia gravis via antigenic modulation of acetylcholine receptorEuropean Journal of Immunology, 1992
- Growth hormone‐albumin conjugates Reduced renal toxicity and altered plasma clearanceFEBS Letters, 1988
- Epitopes on Human Acetylcholine Receptor Defined by Monoclonal Antibodies and Myasthenia Gravis SeraAutoimmunity, 1988
- Demonstration of a main immunogenic region on acetylcholine receptors from human muscle using monoclonal antibodies to human receptorFEBS Letters, 1983
- Passively transferred myasthenia gravis: protection of mouse endplates by Fab fragments from human myasthenic IgG.Journal of Neurology, Neurosurgery & Psychiatry, 1980
- Myasthenic Antibodies Cross-Link Acetylcholine Receptors to Accelerate DegradationNew England Journal of Medicine, 1978
- Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies.The Journal of Experimental Medicine, 1976
- Experimental autoimmune myasthenia: A model of myasthenia gravis in rats and guinea pigs.The Journal of Experimental Medicine, 1975